AIM Vaccine Co (HKSE:06660) EPS (Basic): HK$-0.60 (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06660 AIM Vaccine Co Ltd HKSE:06660
61 GF Score
Price HK$1.69
GF Value HK$4.08
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is AIM Vaccine Co EPS (Basic)?

AIM Vaccine Co HKSE:06660 -0.59% 61 EPS (Basic) is HK$-0.60 as of Jun. 2026. GuruFocus rates HKSE:06660 with a GF Score™ of 61/100 and a GF Value™ of HK$4.08 (Possible Value Trap). The stock has 7 warning signs investors should review.

AIM Vaccine Co's basic earnings per share (Basic EPS) for the six months ended in Jun. 2026 was HK$-0.12. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-0.60.

AIM Vaccine Co's EPS (Diluted) for the six months ended in Jun. 2026 was HK$-0.12. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-0.60.

AIM Vaccine Co's EPS without NRI for the six months ended in Jun. 2026 was HK$-0.11. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2026 was -0.14.

During the past 3 years, the average EPS without NRI Growth Rate was 18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, AIM Vaccine Co's highest 3-Year average EPS without NRI Growth Rate was 31.60% per year. The lowest was -61.70% per year. And the median was 18.70% per year.

AIM Vaccine Co  (HKSE:06660) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

AIM Vaccine Co EPS (Basic) Related Terms

AIM Vaccine Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for AIM Vaccine Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AIM Vaccine Co EPS (Basic) Chart

AIM Vaccine Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial -0.70 -0.30 -1.17 -0.25 -0.61

AIM Vaccine Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.12 -0.13 -0.12 -0.49 -0.12
HKSE:06660
61GF Score
AIM Vaccine Co Ltd HKSE:06660
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AIM Vaccine Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

AIM Vaccine Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-746.198-0)/1223.845
=-0.61

AIM Vaccine Co's Basic EPS for the quarter that ended in Jun. 2026 is calculated as

Basic EPS (Q: Jun. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-142.071-0)/1226.563
=-0.12

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$-0.60 mean?
AIM Vaccine Co (HKSE:06660) has a EPS (Basic) of HK$-0.60 as of Jun. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on AIM Vaccine Co and its competitors.
Is AIM Vaccine Co's EPS (Basic) too high?
AIM Vaccine Co's current EPS (Basic) is HK$-0.60. Overall, AIM Vaccine Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AIM Vaccine Co's EPS (Basic) compare to VRTX and REGN?
AIM Vaccine Co's EPS (Basic) of HK$-0.60 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on AIM Vaccine Co and its competitors. AIM Vaccine Co's current EPS (Basic) is HK$-0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AIM Vaccine Co stock overvalued right now?
Based on GuruFocus' analysis, AIM Vaccine Co (HKSE:06660) is currently considered Possible Value Trap. The stock's GF Value™ is HK$4.08, compared to a current price of HK$1.69 — trading 58.7% below its estimated fair value. The current EPS (Basic) is HK$-0.60. AIM Vaccine Co's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For AIM Vaccine Co (HKSE:06660), the current EPS (Basic) is HK$-0.60 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AIM Vaccine Co (HKSE:06660) Overvalued in 2026?

Based on GuruFocus' analysis, AIM Vaccine Co stock appears to be undervalued. The current stock price of HK$1.69 is trading 58.7% below its estimated GF Value™ of HK$4.08. GuruFocus considers AIM Vaccine Co to be Possible Value Trap.

Key valuation signals for HKSE:06660:

  • EPS (Basic): HK$-0.60
  • GF Value™: HK$4.08 vs. price of HK$1.69 (58.7% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the HKSE:06660 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AIM Vaccine Co Business Description

Address 2 Ronghua South Road, 26th Floor, Building T6, Han’s Plaza, Economic Technological Development Area, Beijing, CHN
AIM Vaccine Co Ltd is a China-based full-chain vaccine company engaged in the research and development, manufacturing, and commercialization of vaccine products. The company's commercialized products include recombinant HBV vaccines, freeze-dried human rabies vaccines, inactivated HAV vaccines, Group A, C, Y, and W135 meningococcal polysaccharide vaccines, bivalent inactivated HFRS vaccines, and mumps vaccines. The company generates the majority of its revenue from the PRC.
61GF Score

Get the complete analysis for HKSE:06660

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.69
Price
HK$4.08
GF Value